<- Go Home
LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Market Cap
$163.0M
Volume
61.3K
Cash and Equivalents
$19.5M
EBITDA
-$7.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$27.3M
Profit Margin
47.86%
52 Week High
$17.31
52 Week Low
$3.21
Dividend
N/A
Price / Book Value
N/A
Price / Earnings
-2.84
Price / Tangible Book Value
N/A
Enterprise Value
$154.1M
Enterprise Value / EBITDA
-23.32
Operating Income
-$11.2M
Return on Equity
304.05%
Return on Assets
-10.10
Cash and Short Term Investments
$25.2M
Debt
$2.5M
Equity
-$8.4M
Revenue
$57.1M
Unlevered FCF
N/A
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium